We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-24.36%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
AUM
$4.79B
AUM Growth
-$1.68B
Cap. Flow
+$133M
Cap. Flow %
2.78%
Top 10 Hldgs %
74.69%
Holding
80
New
4
Increased
7
Reduced
9
Closed
16

Top Sells

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$192M
2
ONON icon
On Holding
ONON
+$178M
3
ERAS icon
Erasca
ERAS
+$73.6M
4
LI icon
Li Auto
LI
+$69.2M
5
AMG icon
Affiliated Managers Group
AMG
+$55.1M

Sector Composition

Rank Sector Weight
1 Healthcare 37.67%
2 Consumer Discretionary 35.71%
3 Technology 14.57%
4 Communication Services 5.27%
5 Consumer Staples 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGNX icon
76
Regenxbio
RGNX
$539M
-456,000
Closed -$14.9M
RLYB icon
77
Rallybio
RLYB
$87.6M
-112,959
Closed -$8.62M
SHCO
78
DELISTED
Soho House & Co
SHCO
-2,009,509
Closed -$25.7M
XPEV icon
79
XPeng
XPEV
$9.83B
-666,500
Closed -$33.5M
RXDX
80
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-200,000
Closed -$7.91M

Similar funds

HHLR Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, HHLR Advisors held 80 positions worth $4.79B, down 26% from $6.47B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

HHLR Advisors's Q1 2022 filing shows 4 new, 7 increased, 9 reduced and 16 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,834,320 shares worth $92.1M. The largest sale was Legend Biotech, an estimated $192M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 48% a quarter earlier, followed by Consumer Discretionary and Technology.

  • HHLR Advisors's largest Q1 2022 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,834,320 shares worth $92.1M.
  • HHLR Advisors added most to DoorDash in Q1 2022, an estimated $280M increase.
  • HHLR Advisors's biggest Q1 2022 reduction was Legend Biotech, cutting an estimated $192M.
  • HHLR Advisors fully exited Erasca in Q1 2022, selling an estimated $73.6M.
  • HHLR Advisors's ten largest holdings make up 75% of its $4.79B portfolio in Q1 2022.
  • HHLR Advisors opened 4 new positions and closed 16 in Q1 2022.
  • HHLR Advisors's portfolio value fell 26% quarter-over-quarter to $4.79B.

Based on HHLR Advisors's 13F filing for Q1 2022, filed 16 May 2022.